BioNTech Inc. (BNTX): Total Asset Value of Company
BioNTech SE (BNTX) has built a powerful network of mRNA-based immunotherapeutic solutions, creating high partner dependency through unique patents. This chart reflects a total asset price trend of 24321.53. The financial model relies on the production of cutting-edge vaccines and personalized cancer treatment. Meanwhile, the company is offsetting the decline in COVID-19 vaccine sales using its substantial cash reserves to invest in costly clinical trials.
Comprehensive metric breakdowns and analytics for BioNTech Group (BNTX)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental valuation:BNTX, biontech.de
Total assets reflect the aggregate volume of resources and liabilities controlled by the issuer to generate profit. This metric is reverse-calculated via return on assets (ROA), allowing the tracking of the cost of borrowed capital's impact on the balance sheet through property and resource forecasting. It is critical for investors to correlate base dynamics with actual returns. For BioNTech SE (BNTX), this capital fuels the development of revolutionary mRNA technologies in the fight against oncology.
Competitors of BioNTech SE (BNTX)
ARGX (argenx.com) - Total Business Assets|Aggregate Company Assets abivax.com ABVX|Total Asset Value of Company ADMA Biologics Inc|Protagonist Therapeutics Inc (PTGX) - Company Total Assets|Aggregate Asset Value Immunovant Therapeutics (IMVT)|Company Total Assets KNSA (Kiniksa Pharmaceuticals)|grifols.com - Company Total Assets|Aggregate Company Assets Adaptive Biotechnologies Corporation (ADPT)|CLDX: Aggregate Asset Value|AUPH (Aurinia Pharma) - Aggregate Company Assets|BioCryst Corp (BCRX) - Cumulative Company Assets|VERA (Vera Therapeutics, Inc.) - Company Total Assets|Company Total Assets dianthustx.com (DNTH)|Pharvaris (PHVS) - Cumulative Company Assets|Aggregate Asset Value AbCellera Biologics (ABCL)|Company Total Assets TRML|Precigen Corp - Company Total Asset Base|PHAR: Aggregate Company Assets|NKTR: Cumulative Company Assets|UPB (Upstream Bio) - Aggregate Company Assets|Cumulative Company Assets Zenas Bio|IMNM (Immunome Corp) - Cumulative Company Assets|Company Total Assets GOSS|Aggregate Company Assets KalVista Pharmaceuticals KALV|Total Business Assets septerna.com (SEPN)|PVLA: Company Total Assets|Company Assets Savara Inc SVRA|RIGL - Company Total Assets|ANAB - Aggregate Company Assets|Astria Therapeutics - Company Total Assets|ENGN (engene.com) - Company Total Asset Base|Aggregate Company Assets RAPT (RAPT Therapeutics)|Company Assets JBIO|Aggregate Company Assets Aclaris ACRS|Total Business Assets Kyverna Therapeutics, Inc KYTX|Cumulative Company Assets Tiziana Life Sciences (TLSA)|Aggregate Business Assets cabalettabio.com CABA|VTYX (Ventyx Biosciences, Inc.) - Company Total Assets|THTX - Company Assets|AVTX (Avalo Therapeutics Inc.) - Company Total Assets|Eledon Pharmaceuticals, Inc (ELDN) - Cumulative Company Assets|AGEN - Company Total Assets|Aggregate Asset Value climbbio.com (CLYM)|Zura Bio (ZURA) - Cumulative Company Assets|Aggregate Asset Value ATYR (aTyr Pharma Inc)|Aggregate Company Assets ADAG|Company Total Asset Base ImageneBio IMA|STTK (Shattuck Therapeutics) - Company Total Assets|EQ - Company Assets|connectbiopharm.com (CNTB) - Company Total Assets|IMUX (Immunic) - Aggregate Company Assets|Aggregate Company Assets Atara Biotherapeutics, Inc. (ATRA)|Total Business Assets InflaRx GmbH (IFRX)|Cumulative Company Assets X4 Pharmaceuticals|Aggregate Business Assets adicetbio.com ACET|CELU - Cumulative Company Assets|INmune Bio Inc - Total Business Assets|Aggregate Company Assets Barinthus Bio|KZR - Total Asset Value of Company|Company Total Assets SAB Biotherapeutics SABS|akaritx.com (AKTX) - Aggregate Asset Value|ENLV (Enlivex Therapeutics Ltd) - Company Total Assets|Company Total Assets QTTB|GeoVax Labs Inc (GOVX) - Aggregate Company Assets|Aggregate Asset Value EDSA (Edesa Biotech Corp)|iBio, Inc. - Aggregate Company Assets|Cumulative Company Assets Carisma Therapeutics Inc CARM|XTL Biopharmaceuticals Ltd. - Company Total Assets|Bolt Biotherapeutics (BOLT) - Company Total Assets|Cumulative Company Assets hcwbiologics.com HCWB|Aptevo Therapeutics Inc. (APVO) - Aggregate Asset Value|AIM: Company Total Assets|Company Total Asset Base ADTX|Aggregate Company Assets GRI (GRI Bio)|Cumulative Company Assets XRTX (XORTX Therapeutics Inc)|ReShape Lifesciences - Aggregate Company Assets|REVB - Cumulative Company Assets|Indaptus Therapeutics - Cumulative Company Assets|SCNI: Company Total Assets|Aggregate Company Assets calcimedica.com|Affimed N.V. (AFMD) - Total Business Assets|Company Total Assets ALLK (Allakos Inc)|Company Assets HOOKIPA|Company Total Assets IGM Biosciences, Inc. (IGMS)|Aggregate Company Assets iteostherapeutics.com (ITOS)|Company Total Assets OCEA|TC BioPharm (Holdings) Plc - Company Total Asset Base|THRD (Third Harmonic Bio, Inc) - Aggregate Company Assets